132 related articles for article (PubMed ID: 1609537)
1. [Current therapy of peripheral arterial occlusive diseases in the aged].
Schütz RM
Z Gerontol; 1992; 25(2):101-4. PubMed ID: 1609537
[TBL] [Abstract][Full Text] [Related]
2. [Current therapy of chronic arterial occlusive diseases of the lower extremities].
Thiele P; Runge E; Hempel G; Gatzweiler C; Geissler S; Schröder HE
Z Gesamte Inn Med; 1987 Dec; 42(23):661-7. PubMed ID: 3328437
[TBL] [Abstract][Full Text] [Related]
3. [Peripheral arterial occlusive disease--acute intervention and after-care].
Stenzinger W; van de Loo J
Z Kardiol; 1993; 82 Suppl 5():71-7. PubMed ID: 8154165
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of peripheral arterial occlusive disease].
Mahler F
Praxis (Bern 1994); 2001 Jan; 90(4):108-12. PubMed ID: 11213570
[TBL] [Abstract][Full Text] [Related]
5. [Fibrinolysis therapy in peripheral arterial occlusions in combination with angioplasty procedures].
Hagg NB
Vasa Suppl; 1991; 33():129-30. PubMed ID: 1838620
[No Abstract] [Full Text] [Related]
6. [Hemorheologic therapy in peripheral arterial occlusive disease].
Kiesewetter H; Jung F
Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
[TBL] [Abstract][Full Text] [Related]
7. Prostanoids in therapy of peripheral arterial occlusive disease.
Creutzig A; Caspary L
Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
[TBL] [Abstract][Full Text] [Related]
8. [Early and late results of conservative therapy in patients with peripheral arterial circulatory disorders of clinical stage IV].
Rieger H; Reinecke B; Levy H
Vasa Suppl; 1984; 12():124-32. PubMed ID: 6592891
[No Abstract] [Full Text] [Related]
9. [The place of local, low-dose, short-duration fibrinolysis in the management concept of arterial occlusive diseases].
Bürkle G; Bürkle H
Rofo; 1991 Nov; 155(5):393-404. PubMed ID: 1835409
[TBL] [Abstract][Full Text] [Related]
10. Conservative management of occlusive peripheral arterial disease.
Spittell JA
Cardiovasc Clin; 1992; 22(3):209-15. PubMed ID: 1600548
[No Abstract] [Full Text] [Related]
11. [Therapy of peripheral arterial occlusive disease with special reference to prostaglandins].
Creutzig A
Z Gesamte Inn Med; 1991 Mar; 46(3):59-67. PubMed ID: 1828125
[TBL] [Abstract][Full Text] [Related]
12. [Overview of the most frequent clinical manifestations of peripheral arterial occlusive disease in the elderly, its diagnosis and stage-related therapy].
Ebert D
Z Arztl Fortbild Qualitatssich; 1997 Sep; 91(6):525-31. PubMed ID: 9441027
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of peripheral occlusive disorders in diabetes mellitus].
Podhaisky H; Hänsgen K
Z Arztl Fortbild (Jena); 1987; 81(17):907-9. PubMed ID: 2964129
[No Abstract] [Full Text] [Related]
14. [Nonsurgical reconstructive treatment of peripheral arterial occlusive disease].
Altmann E; Schmidt PK; Hoffmann A; Spranger C; Förster HJ; Schwabe W
Z Arztl Fortbild (Jena); 1987; 81(17):871-7. PubMed ID: 2964128
[No Abstract] [Full Text] [Related]
15. [Alternative vascular approaches in transluminal angioplasty of infra-inguinal arteries].
Müller W; Fischer M; Bublitz G; Wuppermann T
Vasa Suppl; 1991; 33():200-1. PubMed ID: 1838638
[TBL] [Abstract][Full Text] [Related]
16. [Rational approach to peripheral arterial occlusive disease. Correcting pressure properly].
Wepner U
MMW Fortschr Med; 2004 Feb; 146(7):4-6, 8. PubMed ID: 15347040
[No Abstract] [Full Text] [Related]
17. [Hemodilution in peripheral arterial occlusive disease].
Becsi C; Wehofer D; Weidinger P
Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
[No Abstract] [Full Text] [Related]
18. [Peculiarities of therapy of arterial occlusive disorders in Fontaine stage IV].
Voigt H; Joel A; Köhler H
Z Arztl Fortbild (Jena); 1987; 81(17):903-5. PubMed ID: 3439209
[No Abstract] [Full Text] [Related]
19. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
20. [Rate of recurrence following PTA of pelvic-leg arteries in relation to selected risk factors and antithrombotic after care].
Altmann E; Spranger C; Schweizer J; Hoffmann A; Schmidt PK
Vasa Suppl; 1991; 33():182. PubMed ID: 1838627
[No Abstract] [Full Text] [Related]
[Next] [New Search]
